Results 141 to 150 of about 825 (170)

Blonanserin/olanzapine/risperidone

Reactions Weekly, 2022
openaire   +1 more source

Blonanserin

Reactions Weekly
openaire   +2 more sources

Switching from blonanserin oral tablets/powders to transdermal patches alleviates extrapyramidal symptoms in patients with schizophrenia: A 52-week open-label study

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2022
Kazutaka Ohi, Kentaro Takai, Toshiki Shioiri   +2 more
exaly  

Pharmacokinetic Evaluation of Blonanserin Transdermal Patch: Population Analysis and Simulation of Plasma Concentration and Dopamine D2 Receptor Occupancy in Clinical Settings

Journal of Clinical Pharmacology, 2021
Yoshiko Tomita
exaly  

Blonanserin

Reactions Weekly, 2012
openaire   +1 more source

Blonanserin

Reactions Weekly, 2017
openaire   +1 more source

Simultaneous determination of blonanserin and its metabolite in human plasma and urine by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2012
De-Wei Shang
exaly  

One-year follow-up study of psychotic patients treated with blonanserin: A case series

Asia-Pacific Psychiatry, 2013
Masahiro Suzuki, Sakae Takahashi
exaly  

From Perospirone and Blonanserin to Lurasidone

2021
Ken Inada, Jun Ishigooka, Mitsukuni Murasaki   +2 more
openaire   +1 more source

Atypical antipsychotic properties of blonanserin, a novel dopamine D and 5-HT antagonist

Pharmacology Biochemistry and Behavior, 2010
Yukihiro Ohno, Saki Shimizu
exaly